BridgeBio logo

BridgeBio Employee Directory

Biotechnology ResearchCalifornia, United States1001-5000 Employees

BridgeBio is a biotechnology research company headquartered in Palo Alto, California, United States, with 501-1000 employees. It focuses on developing therapies for genetic conditions, aiming to translate advances in genetic science into real-world patient impact. The company is active in drug development within the biotechnology research sector. In 2026, BridgeBio submitted an NDA to the FDA for encaleret to treat ADH1, and the FDA accepted an NDA for BBP-418 for LGMD2I/R9 with priority review. Public disclosures indicate ongoing regulatory activity and investor coverage related to its programs.

Find BridgeBio employees' phone numbers or email addresses

BridgeBio Global Highlights

Location
Employees

North America
920

Minus sign iconPlus sign icon
  • United States Of America
    919
  • Canada
    1

Europe
44

Minus sign iconPlus sign icon
  • Switzerland
    24
  • Netherlands
    8
  • France
    4
  • United Kingdom Of Great Britain And Northern Ireland
    3
  • Germany
    2
  • Croatia
    1
  • Slovenia
    1
  • Sweden
    1

Asia
11

Minus sign iconPlus sign icon
  • China
    7
  • India
    2
  • Pakistan
    1
  • Indonesia
    1

Africa
1

Minus sign iconPlus sign icon
  • Ghana
    1

Oceania
1

Minus sign iconPlus sign icon
  • Australia
    1

South America
1

Minus sign iconPlus sign icon
  • Argentina
    1

BridgeBio's Leadership

  • Ceo And Founder at BridgeBio
    N. K.
    Ceo And Founder
  • Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio at BridgeBio
    M. O.
    Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio
  • Ceo, Skeletal Dysplasias (qed Therapeutics) at BridgeBio
    J. T.
    Ceo, Skeletal Dysplasias (qed Therapeutics)
  • Cso And Site Head, Gene Therapy at BridgeBio
    C. B.
    Cso And Site Head, Gene Therapy
  • Chief Regulatory Officer at BridgeBio
    A. N.
    Chief Regulatory Officer
  • Chief Operating Officer, Cardiovascular at BridgeBio
    J. L.
    Chief Operating Officer, Cardiovascular
  • Chief Development Officer, Cardiovascular at BridgeBio
    L. K.
    Chief Development Officer, Cardiovascular
  • Chief Accounting Officer at BridgeBio
    A. R.
    Chief Accounting Officer

BridgeBio Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Operations
  • Engineering
  • Finance
  • Program & Project Management
  • Other
  • Sales
  • Biotechnology
  • Legal
  • Administrative
  • Business
  • Quality Assurance
  • Pharmaceuticals

Contact profiles from BridgeBio

Name
Title
Contact
Location
Last Update
  • Head, Global Patient Advocacy | Mocd Type A | Dystrophic Epidermolysis Bullosa at BridgeBio
    A. F.
    Head, Global Patient Advocacy | Mocd Type A | Dystrophic Epidermolysis Bullosa
    Oct 17, 2024
  • Vice President, Talent at BridgeBio
    E. G.
    Vice President, Talent
    Oct 23, 2024
  • Vice President Drug Development Lead, Oncology at BridgeBio
    F. G.
    Vice President Drug Development Lead, Oncology
    Jul 14, 2026
  • Vp Law Commercial And Compliance at BridgeBio
    J. G.
    Vp Law Commercial And Compliance
    Oct 18, 2024
  • Vice President, Clinical Development at BridgeBio
    K. B.
    Vice President, Clinical Development
    Apr 16, 2026
  • Head Of Compliance at BridgeBio
    S. W.
    Head Of Compliance
    Oct 16, 2024
  • Svp, Regulatory Affairs, Interim Head Of Quality at BridgeBio
    V. C. Z.
    Svp, Regulatory Affairs, Interim Head Of Quality
    Oct 17, 2024
  • Executive Director, Medical Affairs at BridgeBio
    A. M.
    Executive Director, Medical Affairs
    Bay
    Aug 07, 2026
  • Director, Marketing at BridgeBio
    L. G.
    Director, Marketing
    Bay
    Jul 29, 2026
  • Executive Director, Antibody Program Lead at BridgeBio
    C. H. Z.
    Executive Director, Antibody Program Lead
    Bay
    Aug 18, 2026

Frequently Asked Questions

What is BridgeBio known for?

Minus sign iconPlus sign icon
BridgeBio was founded in 2014 and operates in the Biotechnology Research industry. Explore BridgeBio's company overview page for more information.

What is BridgeBio's most common email format?

Minus sign iconPlus sign icon
BridgeBio employees' email format typically follows the pattern of First.Last@bridgebio.com. Trying to find reliable and up-to-date employee contact data? Find more BridgeBio email formats with LeadIQ.

How many employees does BridgeBio have currently?

Minus sign iconPlus sign icon
BridgeBio has approximately 1K employees as of August 2026. These team members are located across 6 continents, including North America, Europe and Asia.

Who are BridgeBio's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, BridgeBio's key employees include:

  • Ceo And Founder: N. K.
  • Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio: M. O.
  • Ceo, Skeletal Dysplasias (qed Therapeutics): J. T.
  • Cso And Site Head, Gene Therapy: C. B.
  • Chief Regulatory Officer: A. N.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.